Home » Topics » Regulatory

Regulatory
RSS

Neupro now approved in Europe for all stages of Parkinson's disease

Jan. 17, 2007

Mycamine launched in 100 mg vial format

Jan. 16, 2007

Swedish MPA approves Cipralex in OCD

Jan. 15, 2007

Invega approved for treatment of schizophrenia

Dec. 22, 2006

FDA approval for Invanz

Dec. 22, 2006

Pediatric indication approved for Colazal

Dec. 22, 2006

FDA approval for Bio-E-Gel, to be marketed as Elestrin

Dec. 19, 2006

MuGard receives FDA approval

Dec. 14, 2006

Abilify Injection now available

Dec. 14, 2006

Velcade approved for relapsed mantle cell lymphoma

Dec. 12, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...